Adherence market MedaCube demonstrates a strong value proposition in improving medication adherence from 50% to 97% sustained for a year, aligning with the high-cost burden of non-adherence in the US healthcare system. This creates sales opportunities with healthcare providers aiming to reduce hospital admissions, nursing home placements, and overall costs.

Institutional validation FDA-registered and HIPAA compliant with adoption by reputable institutions such as Mayo Clinic. This credibility supports outreach to hospitals, health systems, and payers as a trusted solution for patient management, remote monitoring, and readmission reduction initiatives.

Caregiver focus Target demographics include patients with dementia and Parkinson’s, along with other chronic conditions, where caregivers seek reliable, automated dispensing. Opportunities exist in home health agencies, independent living facilities, and hospice programs.

Partnership pathways Active interest in collaborations with home health, RN agencies, specialty pharmacies, DME suppliers, and payer/ACO programs. Engage through hospital-at-home models, Medicare Advantage plans, and RHTP/MAHA funding avenues to expand distribution and integration.

Scale and funding Revenue in the low to mid single digits with a modest funding round; potential for growth via multi-site deployments and enterprise contracts. Focus on upsell to care management programs, pharmacy integration, and vendor partnerships to scale adoption.